Cas:1150618-17-9 Di-tert-butyl-2,6-diazaspiro[3.3]heptan-2,6-dicarboxylat manufacturer & supplier

Chemical Name:Di-tert-butyl-2,6-diazaspiro[3.3]heptan-2,6-dicarboxylat

CAS.NO:1150618-17-9

Synonyms:Bis(2-methyl-2-propanyl) 2,6-diazaspiro[3.3]heptane-2,6-dicarboxylate;di-tert-butyl 2,6-diazaspiro[3.3]heptane-2,6-dicarboxylate;Di-tert-butyl-2,6-diazaspiro[3.3]heptan-2,6-dicarboxylat;2,6-Diazaspiro[3.3]heptane-2,6-dicarboxylic acid, bis(1,1-dimethylethyl) ester

Molecular Formula:C₁₅H₂₆N₂O₄

Molecular Weight:298.378

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:379.0±42.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.521

PSA:59.08000

Exact Mass:298.189270

LogP:1.74

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Bis(2-methyl-2-propanyl) 2,6-diazaspiro[3.3]heptane-2,6-dicarboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,6-Diazaspiro[3.3]heptane-2,6-dicarboxylic acid, bis(1,1-dimethylethyl) ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Bis(2-methyl-2-propanyl) 2,6-diazaspiro[3.3]heptane-2,6-dicarboxylate Use and application,2,6-Diazaspiro[3.3]heptane-2,6-dicarboxylic acid, bis(1,1-dimethylethyl) ester technical grade,usp/ep/jp grade.

Related News: Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells. Di-tert-butyl-2,6-diazaspiro[3.3]heptan-2,6-dicarboxylat manufacturer Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells. Di-tert-butyl-2,6-diazaspiro[3.3]heptan-2,6-dicarboxylat supplier The Biogen Inc (BIIB.O) drug, Aduhelm, was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer’s, rather than proof that it slows progression of the lethal mind-wasting disease. Di-tert-butyl-2,6-diazaspiro[3.3]heptan-2,6-dicarboxylat vendor The findings were published June 14 in the journal Nature Aging. Di-tert-butyl-2,6-diazaspiro[3.3]heptan-2,6-dicarboxylat factory The Biogen Inc (BIIB.O) drug, Aduhelm, was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer’s, rather than proof that it slows progression of the lethal mind-wasting disease.